Katharina J. Rauschenbach

Statistics

Publications

Citations

1.3K

H-Index

Active since

2012

Affiliations

University Hospital Heidelberg(Current)

German Cancer Research Center

Heidelberg University

National Center for Tumor Diseases

Katharina J. Rauschenbach is an author at University Hospital Heidelberg specializing in oncology, immunology, and indoleamine 2, 3-dioxygenase pathway.

Publications per year

2012–2016

Publications

A vaccine targeting mutant IDH1 induces antitumour immunity

Theresa Schumacher, Lukas Bunse, Stefan Pusch et al. · Nature · 2014 · 698 citations

Life Sciences, Immunology, Immunization +11

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR

Ulrike Litzenburger, Christiane A. Opitz, Felix Sahm et al. · Oncotarget · 2014 · 313 citations · Full text

Life Sciences, Immunology, Oncology +9

The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas

Jana K. Sonner, Katrin Deumelandt, Martina Ott et al. · OncoImmunology · 2016 · 64 citations · Full text

Life Sciences, Immunology, Oncology +16

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway

Martina Ott, Ulrike Litzenburger, Katharina J. Rauschenbach et al. · Glia · 2014 · 61 citations

Life Sciences, Neuroscience, Oncology +14

Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4

Katharina Ochs, Martina Ott, Katharina J. Rauschenbach et al. · Journal of Neurochemistry · 2015 · 56 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 7